Cytokine storm in HSCT for severe combined immunodeficiency infant with SARS-COV-2: PICU challenges - A case report
Hematopoietic stem cell transplant (HSCT) is the only potentially curative option for severe combined immunodeficiency (SCID) as they are extremely vulnerable to infections. Immunocompromised children are at a higher risk of SARS-CoV-2 infection with prolonged virus shedding, but have a milder disea...
Main Authors: | B Anu Kirthiga, Indira Jayakumar, Ramya Uppuluri, Revathi Raj |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2023-01-01
|
Series: | Journal of Pediatric Critical Care |
Subjects: | |
Online Access: | http://www.jpcc.org.in/article.asp?issn=2349-6592;year=2023;volume=10;issue=2;spage=76;epage=79;aulast=Kirthiga |
Similar Items
-
Risk factors predicting need for the pediatric intensive care unit (PICU) post-hematopoietic cell transplant, PICU utilization, and outcomes following HCT: a single center retrospective analysis
by: Amanda K. Johnson, et al.
Published: (2024-04-01) -
An adaptable in vitro cytokine release assay (CRA): Susceptibility to cytokine storm in COVID-19 as a model
by: Masih Alam, et al.
Published: (2022-01-01) -
Immunomodulating Phytochemicals: An Insight Into Their Potential Use in Cytokine Storm Situations
by: Abdusalam Abdullah Alarabei, et al.
Published: (2024-03-01) -
Description and Analysis of Cytokine Storm in Registered COVID-19 Clinical Trials: A Systematic Review
by: Khalid Eljaaly, et al.
Published: (2021-06-01) -
Cytokine Storm—Definition, Causes, and Implications
by: Dominik Jarczak, et al.
Published: (2022-10-01)